EGFR and hidradenocarcinoma: The current focus for treatment of hidradenocarcinoma is on targeted therapies like trastuzumab, EGFR (epidermal growth factor receptor) inhibitors, PI3K/Akt/mTOR pathway inhibitors, hormonal agents like antiandrogens and electrochemotherapy [16] but more future trials are required.